Inna Ozerov Md Pa is categorized under Noncommercial Research Organizations in Hollywood, FL and active since 2013.
Inna Ozerov Md Pa was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Ozerov Inna at the company’s single location by writing to 7261 Sheridan St # 100b, Hollywood, Florida FL 33024 or by phoning (954) 251-1802. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Inna Ozerov Md Pa |
Contact Person: | Ozerov Inna |
Address: | 7261 Sheridan St # 100b, Hollywood, Florida 33024 |
Phone Number: | (954) 251-1802 |
Website Address: | miamieyesurgeon.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Noncommercial Research Organizations |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Inna Ozerov Md Pa was started in 2013 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ozerov Inna for inquiries that concern Inna Ozerov Md Pa by calling the company number (954) 251-1802, as your correspondence is most welcome. Additionally, the physical location of the single location of Inna Ozerov Md Pa can be found at the coordinates 26.031571,-80.234014 as well as the street address 7261 Sheridan St # 100b in Hollywood, Florida 33024.
For its online presence, you may visit Inna Ozerov Md Pa’s website at miamieyesurgeon.com and engage with its social media outlets through on Twitter and on Facebook.